Full Text (PDF)
Original Article

Injection Sclerotherapy with 3% Polidocanol in 1st and 2nd degree Internal Haemorrhoids – A Prospective Study

Soumya NS , Suresh U Kadli1 , Sharath BV2 , Soumya NS3 , Manjunath Rao SV4 , Rahul Jain5

Author Information

Licence:




New Indian Journal of Surgery 12(3):p 181-183, July-September 2021. | DOI: https://dx.doi.org/10.21088/nijs.0976.4747.12321.10

How Cite This Article:

Suresh U Kadli, Sharath BV, Soumya NS, Manjunath Rao SV/Injection Sclerotherapy with 3% Polidocanol in 1st and 2nd degree Internal Haemorrhoids – A Prospective Study/New Indian J Surg. 2021;12(3): 181–183.


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

nternal Haemorrhoids has been the most common disease since ages and wide variety of treatment modalities available make it an equally enigmatic disease to approach. Polidocanol is the recent sclerosants in the surgeon’s armamentarium for its treatment. This prospective study included 86 patients with first or second degree internal haemorrhoids. Internal haemorrhoids had sexual predilection towards males in our study in the ratio of 2:1 with a age range of 24-68 yrs. Sixty-one of 86 patients had first degree haemorrhoids and the rest 25 had second degree. Bleeding P/R was the most common complaint followed by constipation and perianal discomfort. Response to first dose of 3% polidocanol was seen in 59.3% of patients, 29.07% patient responded to second dose and 11.63% patients responded to the third dose of sclerotherapy. Sclerotherapy is an effective option in the treatment of first and second degree haemorrhoids and 3% polidocanol has been an effective agent in this strategy.

Keywords: Internal haemorroids; Injection sclerotherapy; 3% polidocanol.


References

No records found.


About this article


Cite this article

Suresh U Kadli, Sharath BV, Soumya NS, Manjunath Rao SV/Injection Sclerotherapy with 3% Polidocanol in 1st and 2nd degree Internal Haemorrhoids – A Prospective Study/New Indian J Surg. 2021;12(3): 181–183.


Licence:




Received Accepted Published
N/A N/A N/A

DOI: https://dx.doi.org/10.21088/nijs.0976.4747.12321.10

Keywords


Article Level Metrics

Last Updated

Wednesday 17 June 2026, 17:48:16 (IST)


1735

Accesses

2
222
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share